Abstract LB-C004: Epigenetic immune reprogramming overcomes PD-1 resistance in metastatic melanoma patients: the phase II NIBIT-ML1 study
Year: 2026
Type: conference-abstract
Source: Cancer Immunology Research
Authors: Anna Maria Di Giacomo, Alessia Covre, Maria Fortunata Lofiego, Francesca Pia Caruso, Maura Colucci, Vincenzo D'Alonzo, Raffaella Grifoni, Roberta Depenni, Laura Solmonese, Francesco Marzani, Emma Bello, Antonio De Falco, Monica Valente, Ramiz Rana, Eleonora Carbonari, Giovanni Amato, Elena Manenti, Ilenia Vizzari, Sandra Coral, Harold Keer, Aram Oganesian, Danna Chan, Roberta Mortarini, Maresa Altomonte, Diana Giannarelli, Andrea Anichini, Teresa Maria Rosaria Noviello, Michele Ceccarelli, Michele Maio
Institutions: University of Siena, Biogem, Azienda Usl Toscana Centro, University of Modena and Reggio Emilia, Fondazione IRCCS Istituto Nazionale dei Tumori, Taiho Oncology (United States), Agostino Gemelli University Polyclinic, University of Miami, Sylvester Comprehensive Cancer Center, Network Italiano Per la Bioterapia Dei Tumori
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7133841592
Cites:
Cited by:
Related to: